Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Public ClinicalTrials.gov record NCT00866697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have Not Progressed After First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a study to determine whether therapy with pazopanib was effective and safe in women with epithelial ovarian, fallopian tube, or primary peritoneal cancer whose cancer had not progressed on first line chemotherapy.
Study identification
- NCT ID
- NCT00866697
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 940 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 26, 2009 (Actual)
- Primary completion
- Jul 8, 2012 (Actual)
- Completion
- Aug 24, 2017 (Actual)
- Last update posted
- Feb 16, 2021
2009 – 2017
United States locations
- U.S. sites
- 35
- U.S. states
- 6
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Anaheim | California | 92807 | — |
| Novartis Investigative Site | Baldwin Park | California | 91706 | — |
| Novartis Investigative Site | Bellflower | California | 90706 | — |
| Novartis Investigative Site | Duarte | California | 91010 | — |
| Novartis Investigative Site | Fontana | California | 92335 | — |
| Novartis Investigative Site | Hayward | California | 94545 | — |
| Novartis Investigative Site | Irvine | California | 92618 | — |
| Novartis Investigative Site | Long Beach | California | 90806 | — |
| Novartis Investigative Site | Los Angeles | California | 90027 | — |
| Novartis Investigative Site | Los Angeles | California | 90034 | — |
| Novartis Investigative Site | Los Angeles | California | 90095 | — |
| Novartis Investigative Site | Oakland | California | 94611 | — |
| Novartis Investigative Site | Ontario | California | 91761 | — |
| Novartis Investigative Site | Orange | California | 92868 | — |
| Novartis Investigative Site | Panorama City | California | 91402 | — |
| Novartis Investigative Site | Riverside | California | 92505 | — |
| Novartis Investigative Site | Roseville | California | 95661 | — |
| Novartis Investigative Site | Sacramento | California | 95817 | — |
| Novartis Investigative Site | Sacramento | California | 95825 | — |
| Novartis Investigative Site | San Diego | California | 92108 | — |
| Novartis Investigative Site | San Diego | California | 92120 | — |
| Novartis Investigative Site | San Francisco | California | 94115 | — |
| Novartis Investigative Site | San Jose | California | 95119-1110 | — |
| Novartis Investigative Site | Santa Clara | California | 95051 | — |
| Novartis Investigative Site | South San Francisco | California | 94080 | — |
| Novartis Investigative Site | Vallejo | California | 94589 | — |
| Novartis Investigative Site | Walnut Creek | California | 94596 | — |
| Novartis Investigative Site | Woodland Hills | California | 91367 | — |
| Novartis Investigative Site | Augusta | Georgia | 30912 | — |
| Novartis Investigative Site | Morristown | New Jersey | 07962-1956 | — |
| Novartis Investigative Site | New York | New York | 10032 | — |
| Novartis Investigative Site | New York | New York | 10065 | — |
| Novartis Investigative Site | The Bronx | New York | 10461 | — |
| Novartis Investigative Site | Houston | Texas | 77030 | — |
| Novartis Investigative Site | Annandale | Virginia | 22003 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 283 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00866697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00866697 live on ClinicalTrials.gov.